Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
21.01
+0.36 (1.74%)
At close: Nov 18, 2026, 4:00 PM EST
21.49
+0.48 (2.28%)
After-hours: Nov 18, 2026, 7:45 PM EST
Beam Therapeutics Market Cap
Beam Therapeutics has a market cap or net worth of $2.09 billion as of November 18, 2026. It is the 6,200th most valuable company in the world and the 1,698th biggest in the United States. Its market cap has decreased by 3.64% in one year.
Market Cap
2.09B
Enterprise Value
1.29B
1-Year Change
-3.64%
Global Rank
Country Rank
#1,698 United States
Category
ChartMarket Cap Chart
Since February 6, 2020, Beam Therapeutics's market cap has increased from $327.97M to $2.09B, an increase of 538.49%. That is a compound annual growth rate of 31.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 2.09B | -23.46% |
| Dec 31, 2025 | 2.74B | 38.60% |
| Dec 31, 2024 | 1.97B | -8.58% |
| Dec 29, 2023 | 2.16B | -19.78% |
| Dec 30, 2022 | 2.69B | -49.47% |
| Dec 31, 2021 | 5.33B | 15.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 6, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lakefront Biotherapeutics NV | 2.22B |
| Celldex Therapeutics | 2.20B |
| Palvella Therapeutics | 2.11B |
| Aurinia Pharmaceuticals | 2.06B |
| Immunome | 2.03B |
| Biohaven | 2.00B |
| Harmony Biosciences Holdings | 1.94B |
| Trevi Therapeutics | 1.93B |